Our products are positioned for treatment and prevention of loss of bone structure by natural tooth and/or implant. Periodontitis effects over 50% of adult population whereas peri-implant mucositis and peri-implantitis effect 80% and 28-35% implants. We approach these indications as chronic disorders and therefore seek for long-term sustainable results providing patient with maximal effectiveness of the treatment and long-term minimal costs. Our solutions follow the patient through various cycles, always focused on dental bone as the key to successful therapy.
At the heart of our bone protection products is the innovation of effectively combatting -hard and soft tissue- destructive biofilm: both chemically and mechanically. Intelligent and potent new generation piperacillin/tazobactam antibiotic has been reinforced with regenerative actives and components for different clinical situations. Those regenerative actives and components are needed for implant decontamination and restorative procedures. Products are designed for easy use, are clinically tested and patented.
Retention of teeth is a goal, however, bone retention is becoming even more important as today we have implants.